Equities

Sedana Medical AB (publ)

Sedana Medical AB (publ)

Actions
  • Price (EUR)0.993
  • Today's Change-0.031 / -3.03%
  • Shares traded0.00
  • 1 Year change-30.66%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024 18:31 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of SEK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments382608836
Total Receivables, Net302126
Total Inventory433911
Prepaid expenses4.706.027.12
Other current assets, total------
Total current assets460673881
Property, plant & equipment, net8.331517
Goodwill, net------
Intangibles, net546393270
Long term investments------
Note receivable - long term0.050.050.04
Other long term assets------
Total assets1,0141,0821,168
LIABILITIES
Accounts payable5.171115
Accrued expenses252320
Notes payable/short-term debt000
Current portion long-term debt/capital leases3.295.174.23
Other current liabilities, total9.759.4922
Total current liabilities434961
Total long term debt1.013.584.64
Total debt4.318.748.87
Deferred income tax0.01----
Minority interest------
Other liabilities, total0----
Total liabilities445266
SHAREHOLDERS EQUITY
Common stock2.482.482.48
Additional paid-in capital1,2261,2261,222
Retained earnings (accumulated deficit)(257)(197)(124)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(2.2)(2.65)0.18
Total equity9701,0291,101
Total liabilities & shareholders' equity1,0141,0821,168
Total common shares outstanding999999
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.